Works matching DE "TOCILIZUMAB"

Results: 1265

Targeting IL-6 in antibody-mediated kidney transplant rejection Open Access.

Published in:

Clinical Kidney Journal, 2025, v. 18, n. 5, p. 1, doi. 10.1093/ckj/sfaf108

By:

Kanbay, Mehmet;
Mizrak, Berk;
Copur, Sidar;
Alper, Ezgi N;
Akgul, Sebahat;
Ortiz, Alberto;
Susal, Caner

Publication type:

Article

EFIKASNOST TOCILIZUMABA KOD REZISTENTNE FORME TIROIDNE ORBITOPATIJE.

Published in:

Medical Gazette / Medicinski Glasnik, 2025, v. 30, n. 97, p. 61

By:

Marković, Bojan;
Joksimović, Nata;
Janić, Tamara;
Babić, Jovana;
Miletić, Marija;
Stojković, Mirjana;
Beleslin, Biljana Nedeljković;
ĆIrić, Jasmina;
žArković, Miloš

Publication type:

Article

Effect of Tocilizumab Towards Clinical Outcomes and Safety Among Critically-ill Coronavirus Disease 2019 (Covid-19) Patients: A Retrospective Cohort Study.

Published in:

Malaysian Journal of Medicine & Health Sciences, 2025, v. 21, n. 3, p. 270, doi. 10.47836/mjmhs.21.3.31

By:

Fui-Sing Yap, Diana;
Xin Qian Tan;
Md-Zaini, A'tiqah Syuhada;
Chyun Yaw Ng;
Faharudin, Nur Hanie

Publication type:

Article

Tocilizumab in cranial and extracranial giant cell arteritis: a national multicentre study of 471 cases.

Published in:

Rheumatology, 2025, v. 64, n. 5, p. 2928, doi. 10.1093/rheumatology/keae666

By:

Blanco, Ricardo;
Aldasoro, Vicente;
Maiz, Olga;
Melero, Rafael;
Romero-Yuste, Susana;
Miguel, Eugenio de;
Ferraz-Amaro, Iván;
López-Gutiérrez, Fernando;
Castañeda, Santos;
Loricera, Javier;
Group, the Tocilizumab in Giant Cell Arteritis Spanish Collaborative

Publication type:

Article

Treatment of giant cell arteritis with ultra-short glucocorticoids and tocilizumab: results from the extension of the TOPAZIO study.

Published in:

Rheumatology, 2025, v. 64, n. 5, p. 3057, doi. 10.1093/rheumatology/keae400

By:

Muratore, Francesco;
Marvisi, Chiara;
Cassone, Giulia;
Ricordi, Caterina;
Boiardi, Luigi;
Mancuso, Pamela;
Besutti, Giulia;
Spaggiari, Lucia;
Casali, Massimiliano;
Croci, Stefania;
Durmo, Rexhep;
Versari, Annibale;
Tommaso, Gabriella Di;
Catanoso, Mariagrazia;
Rossi, Paolo Giorgi;
Salvarani, Carlo

Publication type:

Article

Dramatic response to delayed treatment with tocilizumab in new-onset refractory status epilepticus.

Published in:

Neurological Sciences, 2025, v. 46, n. 7, p. 3281, doi. 10.1007/s10072-025-08108-8

By:

Pasqualini, Nicholas;
Falcicchio, Giovanni;
Vogrig, Alberto;
Pellicciari, Roberta;
Defazio, Giovanni;
Gelormini, Domenico;
Liviero, Marilena Casartelli;
Gottin, Leonardo;
Bonetti, Bruno;
Zivelonghi, Cecilia;
Ferlisi, Monica;
Zanoni, Tiziano

Publication type:

Article

Concurrent IgG4-Related Disease and Giant Cell Arteritis: A Rare Case Study.

Published in:

Journal of Rheumatology, 2025, v. 52, n. 6, p. 623, doi. 10.3899/jrheum.2024-0861

By:

Gener, Katrina R.;
Simakova, Ekaterina;
Handal, Marina

Publication type:

Article

Successful treatment of aggressive AA amyloidosis with tocilizumab in a patient with polymyalgia rheumatica.

Published in:

Modern Rheumatology Case Reports, 2025, v. 9, n. 1, p. 214, doi. 10.1093/mrcr/rxae050

By:

Atas, Nuh;
Çalışkan, Ali Rıza;
Akatlı, Ayşenur

Publication type:

Article

Tocilizumab-Based Treatment of Microvascular Inflammation in Kidney Transplant Recipients: A Retrospective Study.

Published in:

Transplant International, 2025, p. 1, doi. 10.3389/ti.2025.14502

By:

Noble, Johan;
Comai, Giorgia;
Corredetti, Valeria;
Laamech, Reda;
Dard, Celine;
Jouve, Thomas;
Giovannini, Diane;
Le Gouellec, Audrey;
Wadnerkar, Shivani;
Cravedi, Paolo;
Apuzzo, Della;
Vetrano, Daniele;
Busutti, Marco;
Abenavoli, Chiara;
Malvezzi, Paolo;
Rostaing, Lionel PE;
Lamanna, Gaetano

Publication type:

Article

Characteristics, Clinical Course, and Outcomes of Critically Ill COVID-19 Associated Mucormycosis—a Case Series Analysis.

Published in:

Indian Journal of Surgery, 2024, v. 86, n. 3, p. 571, doi. 10.1007/s12262-023-03915-9

By:

Vadi, Sonali;
Sanwalka, Neha;
Kale, Hrishikesh;
Bhadwar, Sanjiv;
Kumar, Abhaya

Publication type:

Article

Comparative risk of osteoporotic fracture among patients with rheumatoid arthritis receiving TNF inhibitors versus other biologics: a cohort study.

Published in:

Osteoporosis International, 2020, v. 31, n. 11, p. 2131, doi. 10.1007/s00198-020-05488-9

By:

Shin, A.;
Park, E.H.;
Dong, Y.-H.;
Ha, Y.-J.;
Lee, Y.J.;
Lee, E.B.;
Song, Y.W.;
Kang, E.H.

Publication type:

Article

European Headache Federation recommendations for neurologists managing giant cell arteritis.

Published in:

Journal of Headache & Pain, 2020, v. 21, n. 1, p. 1, doi. 10.1186/s10194-020-01093-7

By:

Mollan, S. P.;
Paemeleire, K.;
Versijpt, J.;
Luqmani, R.;
Sinclair, A. J.

Publication type:

Article

Effect of subcutaneous vs. intravenous tocilizumab in patients with severe COVID-19: a systematic review.

Published in:

European Journal of Clinical Pharmacology, 2024, v. 80, n. 10, p. 1523, doi. 10.1007/s00228-024-03719-0

By:

Li, Yun;
Li, Xianlin;
Zheng, Xiaojun

Publication type:

Article

Safety profile of COVID-19 drugs in a real clinical setting.

Published in:

European Journal of Clinical Pharmacology, 2022, v. 78, n. 5, p. 733, doi. 10.1007/s00228-021-03270-2

By:

Chiu, Mei Nee;
Bhardwaj, Maitry;
Sah, Sangeeta Pilkhwal

Publication type:

Article

Plasma concentrations of remdesivir metabolite in a critical COVID-19 patient needing continuous venovenous haemodialysis.

Published in:

2021

By:

Tempestilli, Massimo;
Stazi, Giulia Valeria;
Maffongelli, Gaetano;
Marini, Maria Cristina;
Ascoli Bartoli, Tommaso;
Ippolito, Giuseppe;
Nicastri, Emanuele;
Marchioni, Luisa;
Agrati, Chiara

Publication type:

Case Study

The effect of tocilizumab on mortality in hospitalized patients with COVID-19: a meta-analysis of randomized controlled trials.

Published in:

European Journal of Clinical Pharmacology, 2021, v. 77, n. 8, p. 1089, doi. 10.1007/s00228-021-03087-z

By:

Kow, Chia Siang;
Hasan, Syed Shahzad

Publication type:

Article

Tocilizumab for treating COVID-19: a systemic review and meta-analysis of retrospective studies.

Published in:

European Journal of Clinical Pharmacology, 2021, v. 77, n. 3, p. 311, doi. 10.1007/s00228-020-03017-5

By:

Zhao, Meng;
Lu, Jieyu;
Tang, Yihu;
Dai, Yawei;
Zhou, Jingxin;
Wu, Yanhu

Publication type:

Article

Evaluation of dose-tapering strategies for intravenous tocilizumab in rheumatoid arthritis patients using model-based pharmacokinetic/pharmacodynamic simulations.

Published in:

European Journal of Clinical Pharmacology, 2020, v. 76, n. 10, p. 1417, doi. 10.1007/s00228-020-02925-w

By:

Bastida, Carla;
Huitema, Alwin D.R.;
l'Ami, Merel J.;
Ruiz-Esquide, Virginia;
Wolbink, Gerrit Jan;
Sanmartí, Raimon;
Soy, Dolors

Publication type:

Article

Tocilizumab in transplantation.

Published in:

European Journal of Clinical Pharmacology, 2020, v. 76, n. 6, p. 765, doi. 10.1007/s00228-020-02864-6

By:

Mosharmovahed, Banafsheh;
Fatahi, Yousef;
Mohebbi, Bahareh;
Ghorbanian, Sohrab Ali;
Assadiasl, Sara

Publication type:

Article

Discontinuation of non-anti-TNF drugs for rheumatoid arthritis in interventional versus observational studies: a systematic review and meta-analysis.

Published in:

European Journal of Clinical Pharmacology, 2018, v. 74, n. 11, p. 1513, doi. 10.1007/s00228-018-2524-3

By:

Tonin, Fernanda S.;
Steimbach, Laiza M.;
Leonart, Leticia P.;
Ferreira, Vinicius L.;
Borba, Helena H.;
Piazza, Thais;
Araújo, Ariane G.;
Fernandez-Llimos, Fernando;
Pontarolo, Roberto;
Wiens, Astrid

Publication type:

Article

Tocilizumab and mesenteric arterial thrombosis: drug-drug interaction with anticoagulants metabolized by CYP 450 and/or by P-glycoprotein.

Published in:

2016

By:

Clarivet, B.;
Robin, P.;
Pers, Y.;
Ferreira, R.;
Lebrun, J.;
Jorgensen, C.;
Hillaire-Buys, D.;
Brés, V.;
Faillie, J.

Publication type:

Letter

Predictors for Long COVID and Differences in Long COVID Symptoms, Findings on Chest Imaging and Pulmonary Function between Hospitalized COVID-19 Patients with versus without Intensive Care Unit Admission.

Published in:

Respiration, 2024, v. 103, n. 5, p. 233, doi. 10.1159/000535391

By:

van Wincoop, Maureen;
Moeniralam, Hazra S.;
Schramel, Franz M.N.H.

Publication type:

Article

Everything you always wanted to know about systemic sclerosis but were afraid to ask: Part 5. Treatment of patients with systemic sclerosis characteristics and treatment recommendations for interstitial lung disease, cardiac involvement, pulmonary arterial hypertension, musculoskeletal, gastrointestinal and renal involvement.

Published in:

Rheumatology Forum, 2023, v. 9, n. 4, p. 199, doi. 10.5603/rf.97832

By:

Bultrowicz, Monika;
Kopeć-Mędrek, Magdalena;
Gumkowska-Sroka, Olga;
Palka, Klaudia;
Kotyla, Przemysław

Publication type:

Article

Drug that calms cytokine storm associated with lower mortality risk among COVID-19 patients.

Published in:: Medical Laboratory Observer (MLO), 2020, v. 52, n. 9, p. 6
Publication type:: Article

Review of Novel Therapies and Update for Takayasu Arteritis and ANCA-Associated Vasculitis with Relevance to the Asia Pacific Region.

Published in:

Journal of Clinical Rheumatology & Immunology (JCRI), 2022, v. 22, n. 1, p. 15, doi. 10.1142/S2661341722300087

By:

Jing Li;
Xinping Tian;
Xiaofeng Zeng

Publication type:

Article

Tocilizumab and Renal Artery Stent--Therapeutic Strategy for Takayasu Arteritis.

Published in:

Journal of Clinical Rheumatology & Immunology (JCRI), 2022, v. 22, n. 1, p. 37, doi. 10.1142/S2661341722720014

By:

Karunanithi, Srividhya;
Nallasivan, Subramanian;
Murugan, Mariappan

Publication type:

Article

Are All Cytokine Storms Born Equal?

Published in:

2025

By:

Kalil, Andre C.;
Abbas, Anum;
Scherger, Sias J.

Publication type:

Opinion

Nonischemic Cardiac Manifestations in VEXAS Syndrome.

Published in:

JAMA Network Open, 2024, v. 7, n. 12, p. e2450251, doi. 10.1001/jamanetworkopen.2024.50251

By:

Robert, Marie;
Mathian, Alexis;
Lacombe, Valentin;
Lobbes, Hervé;
Adélaïde, Léopold;
Le Besnerais, Maelle;
Dacher, Jean-Nicolas;
Terrier, Benjamin;
Mékinian, Arsène;
Bourguiba, Rim;
Georgin-Lavialle, Sophie

Publication type:

Article

Comment on: Benchmarking tocilizumab use for giant cell arteritis.

Published in:

2022

By:

Janagan, Shalini;
Guly, Catherine;
Skeoch, Sarah;
Robson, Joanna C

Publication type:

Letter to the Editor

Real-world evidence on methotrexate-free subcutaneous tocilizumab therapy in patients with rheumatoid arthritis: 24-week data from the SIMPACT study.

Published in:

Rheumatology Advances in Practice, 2022, v. 6, n. 2, p. 1, doi. 10.1093/rap/rkac038

By:

Nagy, György;
Géher, Pál;
Tamási, László;
Drescher, Edit;
Keszthelyi, Péter;
Pulai, Judit;
Czirják, László;
Szekanecz, Zoltán;
Kiss, Gergely;
Kovács, László

Publication type:

Article

Benchmarking tocilizumab use for giant cell arteritis.

Published in:

Rheumatology Advances in Practice, 2022, v. 6, n. 2, p. 1, doi. 10.1093/rap/rkac037

By:

Conway, Richard;
Putman, Michael S;
Mackie, Sarah L

Publication type:

Article

autoinflammatory syndrome with compound heterozygous MEFV and NOD2/CARD15 gene mutations successfully treated with tocilizumab.

Published in:

Rheumatology Advances in Practice, 2022, v. 6, n. 2, p. 1, doi. 10.1093/rap/rkac035

By:

Lee, Jeanie;
Bizzocchi, Lilian;
Jain, Ruchi;
Tagoe, Clement E

Publication type:

Article

Tocilizumab for the treatment of giant cell arteritis in Scotland: a report on behalf of the Scottish Society for Rheumatology standards subgroup.

Published in:

Rheumatology Advances in Practice, 2022, v. 6, n. 1, p. 1, doi. 10.1093/rap/rkac017

By:

Cronin, Owen;
Preston, Hannah;
Fahmy, Heba;
Kuske, Barbara;
Singh, Malinder;
Scott, Naomi;
Kerrigan, Sean;
Moran, Lucy;
Harvie, John;
Harris, Helen;
Hauser, Barbara;
McKay, Neil D

Publication type:

Article

Sarilumab reduces disease activity in rheumatoid arthritis patients with inadequate response to janus kinase inhibitors or tocilizumab in regular care in Germany.

Published in:

Rheumatology Advances in Practice, 2022, v. 6, n. 1, p. 1, doi. 10.1093/rap/rkac002

By:

Tony, Hans-Peter;
Feist, Eugen;
Aries, Peer Malte;
Zinke, Silke;
Krüger, Klaus;
Ahlers, Jonas;
Albrecht, Inka;
Barrionuevo, Christian;
Kalus, Stefanie;
Burkhardt, Harald

Publication type:

Article

Throat swelling following tocilizumab infusion—not always angioedema.

Published in:

2021

By:

Baenziger-Sieber, Patricia;
Daikeler, Thomas;
Negoias, Simona;
Berger, Christoph T

Publication type:

Letter to the Editor

Long-term treatment with tocilizumab in giant cell arteritis: efficacy and safety in a monocentric cohort of patients.

Published in:

Rheumatology Advances in Practice, 2020, v. 4, n. 2, p. 1, doi. 10.1093/rap/rkaa017

By:

Regola, Francesca;
Cerudelli, Elisabetta;
Bosio, Giovanni;
Andreoli, Laura;
Tincani, Angela;
Franceschini, Franco;
Toniati, Paola

Publication type:

Article

Efficacy and safety of subcutaneous tocilizumab in rheumatoid arthritis over 1 year: a UK real-world, open-label study.

Published in:

Rheumatology Advances in Practice, 2019, v. 3, n. 1, p. N.PAG, doi. 10.1093/rap/rkz010

By:

Isaacs, John D;
Salih, Abdelrazig;
Sheeran, Thomas;
Patel, Yusuf I;
Douglas, Karen;
McKay, Neil D;
Naisbett-Groet, Barbara;
Choy, Ernest

Publication type:

Article

Severe destructive arthritis in adult-onset Still's disease.

Published in:

Rheumatology Advances in Practice, 2019, v. 3, n. 1, p. N.PAG, doi. 10.1093/rap/rky052

By:

Daghor, Karima Abbaci;
Berrah, Abdelkrim

Publication type:

Article

Efficacy of Tocilizumab in Refractory Graves Orbitopathy From Real-World Clinical Practice: An Observational Study.

Published in:

Journal of the Endocrine Society, 2024, v. 8, n. 12, p. 1, doi. 10.1210/jendso/bvae193

By:

Wang, Mingyang;
Qin, Bixuan;
Liu, Cuihong;
Liu, Honglei;
Li, Dongmei

Publication type:

Article

Nursing Assessment Is Critical to Optimize Outcomes With Immune Effector Cell--Associated HLH-Like Syndrome.

Published in:

ONS Voice, 2024, p. 2

By:

Georgantzis, Addi

Publication type:

Article

Severe Infections in Patients Treated with Tocilizumab for Systemic Diseases Other Than Rheumatoid Arthritis: A Retrospective Multicenter Observational Study.

Published in:

European Journal of Rheumatology, 2023, v. 10, n. 1, p. 18, doi. 10.5152/eurjrheum.2022.22028

By:

Broca, Florent;
Souchaud-Debouverie, Odile;
Liuu, Evelyne;
Roblot, Pascal;
Martin, Mickaël

Publication type:

Article

What are the main factors affecting the outcome of tocilizumab therapy in COVID-19-induced cytokine release syndrome?

Published in:

European Journal of Rheumatology, 2022, v. 9, n. 3, p. 126, doi. 10.5152/eurjrheum.2022.21010

By:

Akleylek, Cansu;
Gűr, Seray Gizem;
Sever, Ibrahim Halil;
Demir, Safiye Koçulu;
Çevik, Esin;
Eken, Egemen;
Gőkkaya, Zafer;
Çağatay, Yonca;
Yılmaz, Neslihan

Publication type:

Article

Serum interleukin-6 in seropositive rheumatoid arthritis and response to tocilizumab: An observational study.

Published in:

European Journal of Rheumatology, 2022, v. 9, n. 1, p. 26, doi. 10.5152/eurjrheum.2021.20202

By:

Kumar, Abhishek;
Bhakuni, D. S.;
Kartik, Sivasami;
Hegde, Arun;
Shanmuganandan, K.;
Singh, Kavita;
Vasdev, Vivek;
M. N., Arjun

Publication type:

Article

Use of non-TNF biologics for the treatment of neuro- Behçet's disease: Literature review and 2 refractory cases of monoclonal anti-TNFs treated with tocilizumab.

Published in:

European Journal of Rheumatology, 2021, v. 8, n. 4, p. 223, doi. 10.5152/eurjrheum.2021.20160

By:

Karabulut, Yusuf

Publication type:

Article

Recurrence of proteinuria after cessation of tocilizumab in patients with AA amyloidosis secondary to FMF.

Published in:

European Journal of Rheumatology, 2018, v. 5, n. 3, p. 153, doi. 10.5152/eurjrheum.2018.17183

By:

Yılmaz, Sedat;
Tekgöz, Emre;
Çınar, Muhammet

Publication type:

Article

Drug Persistence and Incidence of Active Tuberculosis of Tumor Necrosis Factor Alpha Inhibitors Versus Tocilizumab as the First-Line Biological Treatment in Patients with Rheumatoid Arthritis: A Nationwide Population-Based Retrospective Cohort Analysis.

Published in:

Rheumatology & Therapy, 2024, v. 11, n. 4, p. 881, doi. 10.1007/s40744-024-00674-1

By:

So, Min Wook;
Kim, A-Ran;
Lee, Seung-Geun

Publication type:

Article

Inflammatory Markers are Quickly Improved by Tocilizumab in Early Polymyalgia Rheumatica and Might Predict Early Response to Interleukin-6 Blockade.

Published in:

Rheumatology & Therapy, 2021, v. 8, n. 2, p. 751, doi. 10.1007/s40744-021-00299-8

By:

Carvajal Alegria, Guillermo;
Cornec, Divi Y. K.;
Renaudineau, Yves;
Saraux, Alain;
Devauchelle-Pensec, Valérie

Publication type:

Article

Effect of Tocilizumab on LDL and HDL Characteristics in Patients with Rheumatoid Arthritis. An Observational Study.

Published in:

Rheumatology & Therapy, 2021, v. 8, n. 2, p. 803, doi. 10.1007/s40744-021-00304-0

By:

Pierini, Florencia S.;
Botta, Eliana;
Soriano, Enrique R.;
Martin, Maximiliano;
Boero, Laura;
Meroño, Tomás;
Saez, María Soledad;
Lozano Chiappe, Ezequiel;
Cerda, Osvaldo;
Citera, Gustavo;
Gandino, Ignacio;
Rosa, Javier;
Sorroche, Patricia;
Kontush, Anatol;
Brites, Fernando

Publication type:

Article

Durability of Response to Tocilizumab Therapy in Rheumatoid Arthritis: Data from the US-Based Corrona Rheumatoid Arthritis Registry.

Published in:

Rheumatology & Therapy, 2021, v. 8, n. 1, p. 467, doi. 10.1007/s40744-021-00285-0

By:

Pappas, Dimitrios A.;
Blachley, Taylor;
Best, Jennie H.;
Zlotnick, Steve;
Reiss, William G.;
Emeanuru, Kelechi;
Kremer, Joel M.

Publication type:

Article

Real-World 1-Year Retention Rate of Subcutaneous Tocilizumab Treatment in Patients with Moderate to Severe Active Rheumatoid Arthritis: TANDEM Study.

Published in:

Rheumatology & Therapy, 2021, v. 8, n. 1, p. 95, doi. 10.1007/s40744-020-00253-0

By:

Hilliquin, Pascal;
Barnetche, Thomas;
Baillet, Athan;
Flipo, René-Marc;
Lespessailles, Eric;
Roux, Christian;
Fardellone, Patrice;
Gilbert-Marceau, Anika;
Idier, Isabelle;
Constantin, Arnaud;
Shipley, Emilie;
Baudens, Guy;
Saraux, Alain

Publication type:

Article